These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 33322348

  • 1. Alexander Disease Modeling in Zebrafish: An In Vivo System Suitable to Perform Drug Screening.
    Candiani S, Carestiato S, Mack AF, Bani D, Bozzo M, Obino V, Ori M, Rosamilia F, De Sarlo M, Pestarino M, Ceccherini I, Bachetti T.
    Genes (Basel); 2020 Dec 11; 11(12):. PubMed ID: 33322348
    [Abstract] [Full Text] [Related]

  • 2. Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.
    Lee SH, Nam TS, Kim KH, Kim JH, Yoon W, Heo SH, Kim MJ, Shin BA, Perng MD, Choy HE, Jo J, Kim MK, Choi SY.
    BMC Neurol; 2017 Sep 07; 17(1):175. PubMed ID: 28882119
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beneficial effects of curcumin on GFAP filament organization and down-regulation of GFAP expression in an in vitro model of Alexander disease.
    Bachetti T, Di Zanni E, Balbi P, Ravazzolo R, Sechi G, Ceccherini I.
    Exp Cell Res; 2012 Sep 10; 318(15):1844-54. PubMed ID: 22705585
    [Abstract] [Full Text] [Related]

  • 7. In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation.
    Bachetti T, Di Zanni E, Balbi P, Bocca P, Prigione I, Deiana GA, Rezzani A, Ceccherini I, Sechi G.
    Exp Cell Res; 2010 Aug 01; 316(13):2152-65. PubMed ID: 20471977
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response.
    Hagemann TL, Connor JX, Messing A.
    J Neurosci; 2006 Oct 25; 26(43):11162-73. PubMed ID: 17065456
    [Abstract] [Full Text] [Related]

  • 10. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
    Pekny T, Faiz M, Wilhelmsson U, Curtis MA, Matej R, Skalli O, Pekny M.
    APMIS; 2014 Jan 25; 122(1):76-80. PubMed ID: 23594359
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A case of severe Alexander disease with de novo c. 239 T > C, p.(F80S), in GFAP.
    Matsumoto A, Tulyeu J, Furukawa R, Watanabe C, Monden Y, Nozaki Y, Mori M, Namekawa M, Jimbo EF, Aihara T, Yamagata T, Osaka H.
    Brain Dev; 2018 Aug 25; 40(7):587-591. PubMed ID: 29573842
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease.
    Heaven MR, Wilson L, Barnes S, Brenner M.
    J Biol Chem; 2019 Oct 25; 294(43):15604-15612. PubMed ID: 31484723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.